|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/00 | (2006.01) |
| A61K2039/505 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| C07K2317/24 | (2013.01) | ||
| C12N 5/07 | (2010.01) | ||
| C07K2317/567 | (2013.01) | ||
| C07K2317/72 | (2013.01) | ||
| C07K2317/73 | (2013.01) | ||
| C07K2317/732 | (2013.01) | ||
| C07K2317/734 | (2013.01) | ||
| C07K2317/92 | (2013.01) | ||
| C07K 16/3084 | (2013.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/02 | (2018.01) |
| (11) | Number of the document | 3323830 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17191451.8 |
| Date of filing the European patent application | 2011-06-20 | |
| (97) | Date of publication of the European application | 2018-05-23 |
| (45) | Date of publication and mention of the grant of the patent | 2023-08-23 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 397920 P | 2010-06-19 | US |
| (72) |
Cheung, Nai-Kong , US
Ahmed, Mahiuddin , US
|
| (73) |
Memorial Sloan-Kettering Cancer Center ,
1275 York Avenue, New York, NY 10065,
US
|
| (54) | ANTI-GD2 ANTIBODIES |
| ANTI-GD2 ANTIBODIES |